LRRK2-IN-1 is a cell-permeable, ATP competitive, potent, and selective LRRK2 inhibitor. IC50 is 13 nM, 6 nM, and 2.45 M for wild type, G2019S mutant, and drug resistant A2016T mutant LRRK2, respectively.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | LRRK2-IN-1 |
Iupac 化学名称 | 2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one |
同义词 | LRRK 2-IN-1 |
英文同义词 | LRRK 2-IN-1 |
分子式 | C31H38N8O3 |
分子量 | 570.69 |
Smile | COC1=C(NC=2N=CC3=C(N(C4=C(C(N3C)=O)C=CC=C4)C)N2)C=CC(=C1)C(=O)N1CCC(CC1)N1CCN(CC1)C |
InChiKey | IWMCPJZTADUIFX-UHFFFAOYSA-N |
InChi | InChI=1S/C31H38N8O3/c1-35-15-17-38(18-16-35)22-11-13-39(14-12-22)29(40)21-9-10-24(27(19-21)42-4)33-31-32-20-26-28(34-31)36(2)25-8-6-5-7-23(25)30(41)37(26)3/h5-10,19-20,22H,11-18H2,1-4H3,(H,32,33,34) |
Cas号 | 1234480-84-2 |
相关CAS号 | |
外观性状 | Solid powder |
纯度 | 97% |
存储 | -20 ºC for 3 years |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |